Berlin – Die European Liver Patients Association (ELPA) hat heute die erste europaweite und patientengeführte Studie zu Lücken in der Versorgung von Patienten mit Hepatitis B und C vorgestellt. (aerzteblatt.de, 21.12.2016) http://ww…

Immune reconstitution following HCV clearance with direct antiviral agents: potential consequences for patients with HCC? Werner JM, Adenugba A, Protzer U. Transplantation. 2016 Dec 8. [Epub ahead of print] PMID: 27941432 Abstract https://…

Bidischa Chatterjee, Gefängnisärztin, Bern Nationales Symposium Hepatitis C 2016 Kampagne hepatitis C: „Neue Chancen – neue Herausforderungen?“, 29. September 2016, Kongresszentrum Biel http://www.infodrog.ch/tl_f…

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus (HCV). Around 115 million people worldwide have been infected at some point in their life by HCV. Two-thirds of these are estimated to be chronically infec…

Antineutrophil cytoplasmic antibodies crescentic allograft glomerulonephritis after sofosbuvir therapy. Gadde S, Lee B, Kidd L, Zhang R. World J Nephrol. 2016 Nov 6;5(6):547-550. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099601/

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2016 At its meeting this week, the Pharmacovigilance Risk Assessment Committee (PRAC) (...) warns of risk of hepatitis B re-…